NCT05035238
Evaluation of the Efficacy, Safety and Immunogenicity of Inactivated COVID 19 Vaccine(TURKOVAC) in Healthy Population of 18 and 64 Years of Age (Both Inclusive):a Randomized, Double-blind, Phase IIb Clinical Trial
Phase: Phase 2
Role: Collaborator
Start: Oct 1, 2021
Completion: Oct 1, 2021